Skip to main content

DH statement on MenB vaccine

Posted by: , Posted on: - Categories: Vaccinations and Immunisations

A Department of Health spokesperson said:

“Our thoughts are with Faye's family at this difficult time.

“New immunisation programmes are always introduced based on the best independent clinical recommendations to ensure we can protect those children most at risk.

“When our nationwide MenB vaccination programme was introduced last year, the UK became the first country to protect our babies from this devastating disease. All children who are now aged up to 9 months should have been offered the vaccine."


The Department of Health is advised on immunisation matters, including the effectiveness and cost-effectiveness of new vaccines by the independent expert body, the Joint Committee on Vaccination and Immunisation (JCVI) - The JCVI advised that the Meningococcal B vaccination programme should aim to protect infants before they reach five months of age because this is when the risk is greatest. The vaccine is first offered to children from 2 months of age.

MenB immunisation was introduced from 1 September for those babies who are due to receive their primary immunisations starting at 2 months of age on or after 1 September 2015 (i.e. those born on or after 1 July 2015), with a one-off catch-up programme for those infants born from 1 May 2015 to 30 June 2015.

Children who are now aged up to 9 months should have been offered the vaccine.

When any new immunisation programme is introduced, there has to be a cut-off date to determine eligibility. We recognise that this is extremely difficult for parents of babies who narrowly fall on the wrong side of the cut-off date, but there is no other way of realistically starting new programmes.

The JCVI advice on MenB is below.


Sharing and comments

Share this page